Our Story
Opticann Inc. was founded by pioneers in the medical cannabis space who come from the healthcare and pharmaceutical industries. Established by former MedReleaf and Cynapsus Therapeutics executives, Opticann’s pharmaceutical-focused team has 40 years’ combined experience in the pharmaceutical industry and over 20 years of experience in clinical medicine and medical cannabis product development.
We produce and market world-class medical cannabis products in Canada, the U.S. directly and through strategic partners in Australia and New Zealand.
Our Mission
Licensed by Health Canada
Opticann's CB4™ brand of medical cannabinoid products are produced at our Health Canada licensed producer facility, Cannacure Corporation in Fort Erie, Ontario.
We Believe...
- Millions of people with a wide range of medical ailments can benefit from pharmaceutically formulated, tested and safe medical cannabinoid products
- In dedicating our research and development for highly effective cannabinoid products based on advanced pharmaceutical technology
- Healthcare providers will be more willing to use medical cannabinoid products that are well formulated and are backed by objective evidence on efficacy and safety
- Our fast-acting, long-lasting, and safe products have the power to improve the lives of many who are dealing with chronic medical conditions
Evidence Based Cannabinoids
Opticann believes the therapeutic and medical potential of the multitude of active cannabinoids (over 100 identified by researchers) and terpenes in cannabis can effectively help millions of people with multiple disease conditions. This revolution in medical treatment with cannabinoids started with THC and CBD and is expanding rapidly as research and understanding of other cannabinoids in the cannabis and hemp plants increases.
Many medical patients and their healthcare practitioners are still developing their understanding of the therapeutic potential of cannabinoids for improving peoples’ lives. Our goal is to help accelerate this education and provide the most effective products based on scientific evidence and innovative technology.
Trusted Pharmaceutical Technology
Opticann’s CB4™ brand of medical cannabinoid products are based on trusted pharmaceutical technology platforms that are proven to enhance performance of products—for rapid and maximum effect, while minimizing unwanted effects.
Our CBD product formats may be familiar to most medical patients: oral capsules, sublingual strips, and topically administered products in the form of creams and gels. All Opticann products are based on innovative pharmaceutical technology that deliver results consistently, safely, and in convenient dosage forms. These dosage forms are clinically tested and optimized to deliver active ingredients for effective results.
Our Promise to All Patients:
- To only bring you products that are well tested to be effective—medicine that we give to our own families
- A commitment to high quality manufacturing practices that meet or exceed strict regulatory requirements (manufacturing under cGPP or cGMP conditions)
- Research and development that results in scientifically validated products proven to be efficacious with data that is published in peer-reviewed journals
- An ongoing commitment to building an ongoing relationship with our patients and providing compassionate care
Our Commitment
Online Shop
Opticann’s full suite of medical cannabis products are available to purchase online in Canada through our Patient Portal for registered patients. We welcome you to become a patient and register with us for access to effective medical cannabis products.
To get in touch with Opticann management or a team member, please email us at: [email protected] and we will get back to you as soon as possible.